SCHEMBL29453670

SCHEMBL29453670

COc1ccc(CC2(C#N)CCN(C(=O)c3cccnc3-c3ccncn3)CC2)cn1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 9/20 0.56
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ GABRA5 P31644 3/20 0.38
▸ CTSL P07711 1/20 0.37
▸ CTSB P07858 1/20 0.37
▸ CTSS P25774 1/20 0.37
▸ GPR183 P32249 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ ENPP2 Q13822 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ SPR P35270 1/20 0.33
▸ CCR8 P51685 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719321 1.00 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453669 0.90 CYP46A1 (0.60) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719461 0.90 CYP46A1 (0.60) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719147 0.89 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453714 0.89 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719186 0.88 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453681 0.88 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719400 0.87 CYP46A1 (0.64) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719174 0.87 CYP46A1 (0.64) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453698 0.87 CYP46A1 (0.64) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback